AEDs Flashcards
1
Q
Phenobarbital - MOA
A
- GABA a agonist
- prolongs opening of Cl channels
2
Q
Phenobarbital - SE
A
- mood changes (depression)
- sedation
- Dupuytren contracture
- decreased bone density
3
Q
Primidone - MOA
A
- Hepatic P450 inducer
- Converted in the liver into phenobarbital and PEMA (phenylethylmalonamide)
4
Q
Primidone - SE
A
- sedation
- mood changes (depression)
- decreased bone density
- toxic effect: nausea, vomiting, ataxia, dizziness
5
Q
Phenytoin - MOA
A
- Hepatic P450 inducer
- sodium channel blocker: binds to ACTIVE state of sodium channel to prolong its fast inactivated state (therefore reduces high frequency firing)
6
Q
Phenytoin - SE
A
- IV: purple glove syndrome, hypotension, arrhythmia, burning pain, cellulitis
- Toxic: ataxia, incoordination, nystagmus, dysarthria, diplopia
- ginger hyperplasia
- osteoporosis
- SJS
- peripheral neuropathy
- cerebellum atrophy
7
Q
Carbamazepine - MOA
A
- Hepatic P450 inducer (induces its own metabolism)
- sodium channel blocker: binds to ACTIVE state of sodium channel to prolong its fast inactivated state (therefore reduces high frequency firing)
- Important metabolite—> carbamazepine-10, 11-epoxide (levels increase with VALPORIC ACID)
8
Q
Carbamazepine - SE
A
- nausea
- Toxic: blurred vision, ataxia, diplopia, TREMOR
- hyponatremia
- decreased bone density
- weight gain
- SJS, toxic epidermal necrolysis HLA-B1502 allele, Asian decent
- heptatotoxicity
9
Q
Oxcarbazepine - MOA
A
-Binds to sodium channel, inhibiting high frequency firing (just like phenytoin and
carbamazepine)
-Converted to active metabolite licarbazepine
-Protein binding not important (unlike Carbamazepine)
10
Q
Oxcarbazepine - SE
A
- Drowsiness
- Fatigue
- Headache
- Higher doses as per carbamazepine
- Hyponatremia
- Rash
11
Q
Eslicarabazepine - MOA
A
- Active metabolite S-licarabazepine
- Blockers sodium channel and stabilizes inactive state
12
Q
Eslicarabazepine - SE
A
- Drowsiness
- Fatigue
- Headache
- Higher doses as per carbamazepine
- Hyponatremia
- Rash
13
Q
Valporic Acid - MOA
A
- Hepatic P450 inhibitor
- GABA potentiation
- Blocking T type Ca channels
- Blocking sodium channels
14
Q
Valporic Acid - SE
A
- weight gain
- tremor
- teratogenic (decreased IQ, cleft palate, neural tube defects, cardiovascular malformations)
- pancreatitis!
- sedation
- hair loss
- hepatotoxicity
- THROMBOCYTOPENIA
15
Q
Ethosuxsimide - MOA
A
Blocks T type calcium channels